2005
DOI: 10.1016/j.tet.2005.06.003
|View full text |Cite
|
Sign up to set email alerts
|

Dde-protected PNA monomers, orthogonal to Fmoc, for the synthesis of PNA–peptide conjugates

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
36
0

Year Published

2006
2006
2021
2021

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 29 publications
(36 citation statements)
references
References 22 publications
0
36
0
Order By: Relevance
“…The polyamine was added to the resin and the reaction proceeded for 3 h at room temperature. Next, the primary amines were selectively protected using DDE . The secondary amines were protected using di‐tertbutyl‐dicarbonate.…”
Section: Methodsmentioning
confidence: 99%
“…The polyamine was added to the resin and the reaction proceeded for 3 h at room temperature. Next, the primary amines were selectively protected using DDE . The secondary amines were protected using di‐tertbutyl‐dicarbonate.…”
Section: Methodsmentioning
confidence: 99%
“…62 The synthesis of branched peptide-PNA conjugates requires a more flexible strategy, since the PNA and the peptide should be elongated in a truly orthogonal fashion. 63,64 It is desirable that the N-terminal protecting group on PNA monomers PG 1 (Figure 4.1) is stable under the cleavage conditions for the N-terminal protecting group on amino acid monomers (PG N ; usually the Fmoc group) and their acid-labile side-chain protecting groups PG R . At the same time the protecting groups on the nucleobases and on the amino acid sidechains should be cleaved together under the final deprotection conditions.…”
Section: Continuous Synthesismentioning
confidence: 99%
“…Thus, PNA monomers with a 1-(4,4-dimethyl-2,6-dioxacyclohexylidene)ethyl (Dde) protecting group on the N-terminus and Mmt on the nucleobases appears to be fully orthogonal to the commercially available Fmoc amino acid monomers. 63,64 The orthogonality of Dde and Fmoc groups is based on their different mechanisms for deprotection. While Fmoc is cleaved by basic elimination, Dde is removed by treatment with nucleophiles (trans-elimination).…”
Section: Continuous Synthesismentioning
confidence: 99%
“…3 Furthermore, PNA is stable over a wide pH range and is resistant to both nucleases and proteases, 4 making PNA a molecule of choice for gene therapy applications, and also for high-throughput analysis using PNA microarrays, although these have been little explored. [5][6][7][8][9] The orthogonal, solid phase, synthesis of PNA-peptide conjugates using a Dde/Fmoc strategy with Dde/Mmt protected PNA monomers 1-4 (Scheme 1) and Fmoc/ t Bu protected amino acids has been reported previously, [10][11][12][13] however, this approach is time consuming and non-automated, limiting wider applications of PNA in chemistry and biology. Here we report an automated orthogonal microwave synthesis of PNA-peptide conjugates, and illustrate this strategy with the synthesis of two specific receptor-based, cellular binding, PNA-encoded peptide ligands, ArgGly-Asp-12-mer-PNA and Arg-Gly-Glu-12-mer-PNA.…”
mentioning
confidence: 99%
“…Here we report an automated orthogonal microwave synthesis of PNA-peptide conjugates, and illustrate this strategy with the synthesis of two specific receptor-based, cellular binding, PNA-encoded peptide ligands, ArgGly-Asp-12-mer-PNA and Arg-Gly-Glu-12-mer-PNA. 11,12,13 Resin 5 (Scheme 2) and the PNA monomers 1-4 were synthesized according to previously reported procedures, 10 with the sole exception that the coupling of the functionalized nucleobases to the backbone was carried out with solid-supported dicyclohexylcarbodiimide (PS-DCC) rather than conventional DCC. 14,15 PNA-peptide synthesis was carried out in an automated CEM peptide synthesizer.…”
mentioning
confidence: 99%